hodgkin's%20lymphoma
HODGKIN'S LYMPHOMA

Hodgkin's lymphoma is a malignancy that arises from germinal center B cell.

Histologically, there is a presence of multinucleated giant cells in a mixed inflammatory background.

It is also known as Hodgkin's disease, Hodgkin lymphoma or Hodgkin disease.

It commonly affects individuals ages 15-30 years old and those 55 years old and above.

The key morphologic characteristics include presence of Reed-Sternberg cells and lymphocyte-predominant cells.

Introduction

  • Also known as Hodgkin’s disease, Hodgkin lymphoma, or Hodgkin disease
  • Commonly affects ages 15-30 years old, & individuals 55 years old & above
  • Key morphologic characteristics include presence of Reed-Sternberg cells & lymphocyte-predominant cells
  • Divided into 2 types: Classic Hodgkin's lymphoma (CHL) & nodular lymphocyte-predominant Hodgkin's lymphoma (NLPHL)

Definition

  • A malignancy involving the lymph nodes & the lymphatic system

Etiology

  • Viruses (eg Epstein-Barr virus)
  • Positive family history of hematopoietic malignancy & autoimmune/chronic inflammatory diseases
  • Positive family history of Hodgkin's lymphoma

Prognostic Factors

  • Presence of the following reduces the survival rate by 7-8%/year
    • Age >45 years old
    • Gender - males are at increased risk
    • Patients diagnosed with stage IV disease
    • Albumin level: <4 g/dL
    • Hemoglobin (Hgb) level: <10.5 g/dL
    • Leukocytosis [White blood cell (WBC) >15,000/mm3]
    • Lymphocytopenia [Lymphocyte count <8% of white blood cell (WBC) &/or <600/mm3]

Signs and Symptoms

  • Assess patient’s performance status based on the clinical presentation
  • Painless peripheral adenopathies (commonly within the cervical or supraclavicular areas)
  • Chest pain or pain within the mediastinum
  • Pain at a nodal site after drinking alcohol
  • Chronic pruritus
  • Systemic B symptoms
    • Fever (>38oC/100.4oF)
    • Night sweats
    • Weight loss (>10% of baseline)
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Oncology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
29 Nov 2017
Rapid onset opioids may allow for more effective treatment of breakthrough cancer pain as their pharmacokinetic profile closely mimics the pain’s time course
Christina Lau, 22 Oct 2015
A 21-gene expression assay can identify patients with early-stage breast cancer who can skip adjuvant chemotherapy without facing an increased risk of recurrence at 5 years.
Cathy Chow, PhD, 27 Aug 2015

HER2-positive breast cancer tends to be more aggressive, has worse patient prognosis, and responds less to treatment. A two-pronged approach to block the HER pathway via pertuzumab (Perjeta®, Roche), a first-in-class HER dimerization inhibitor, in combination with trastuzumab and chemotherapy, may offer more treatment options for HER2-positive metastatic breast cancer patients as well as those with early breast cancer. 

Saras Ramiya, 25 Oct 2017
The first patient-reported outcomes study on durvalumab treatment after chemoradiation in locally advanced non-small cell lung cancer (NSCLC) shows patients’ quality of life is similar to that of the patients who received placebo.